EDINBURGH, Scotland, Sept. 26, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the launch of the GUIDE™ XT System for visualization of Deep Brain Stimulation (DBS) in ...

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is used for advanced Parkinson’s disease treatment to improve the quality of life of patients by alleviating motor symptoms, as well as ...

July 11, 2006 — A small study suggests that in Parkinson's patients who already have a stable response to subthalmic nucleus (STN) deep brain stimulation (DBS), "tweaking" of the electrical ...

Boston Scientific, Inc. BSX recently obtained a CE Mark on the Vercise Neural Navigator 5 Software with STIMVIEW XT technology. When used as an element of the Vercise Genus Deep Brain Stimulation (DBS ...

The FDA approved Medtronic's BrainSense Adaptive DBS for Parkinson's, offering personalized therapy through automatic adjustments to patients' needs. The ADAPT-PD trial validated aDBS's safety and ...

Tardive dyskinesia (TD) can be addressed by the right intervention even in severe, refractory cases. These cases, characterized by involuntary muscle movements, are most often caused by antipsychotics ...

For patients with Parkinson's disease, changes in their ability to walk can be dramatic. "Parkinson's gait," as it is often called, can include changes in step length and asymmetry between legs. This ...